Urethral discharge

F Dal Moro - CMAJ, 2013 - Can Med Assoc
Although we agree with Klassen and colleagues1 that their patient's acute interstitial
nephritis was most likely caused by pantoprazole, we note that the patient was also on …

What about the role of sulfasalazine?

CA Dargavel, K Khan - CMAJ, 2013 - Can Med Assoc
Although we agree with Klassen and colleagues1 that their patient's acute interstitial
nephritis was most likely caused by pantoprazole, we note that the patient was also on …

Dementia and history of trauma

SD Russell - CMAJ, 2013 - Can Med Assoc
Although we agree with Klassen and colleagues1 that their patient's acute interstitial
nephritis was most likely caused by pantoprazole, we note that the patient was also on …

Drug-induced Interstitial Nephritis in a Patient with Ulcerative Colitis Treated with 5-Aminosalicylic Acid

D Hayashi, T Nishida, N Osugi, Y Kusunoki… - Internal …, 2024 - jstage.jst.go.jp
This report describes the case of a 76-year-old man with ulcerative colitis who developed
interstitial nephritis after starting 5-Aminosalicylic acid (5-ASA) therapy. The patient …

Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine

H Skhiri, B Knebelmann, L Martin-Lefevre, JP Grunfeld - Nephron, 1998 - karger.com
Dear Sir, 5-Aminosalicylic acid has recently been introduced for the treatment of
inflammatory bowel disease (IBD). Few cases of nephrotoxicity have been reported [1]. We …

[HTML][HTML] Case Report: Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event

P Magalhães-Costa, L Matos, C Chagas - BMJ Case Reports, 2015 - ncbi.nlm.nih.gov
The 5-aminosalicylate is widely prescribed in inflammatory bowel disease patients. Its
potential for renal damage has been seldom described. We report a case of a 23-year-old …

OC-050 5-Aminosalicylate (5-Asa) Induced Nephrotoxicity in Inflammatory Bowel Disease

K So, C Bewshea, GA Heap, AF Muller… - Gut, 2013 - gut.bmj.com
Introduction Nephrotoxicity is a rare idiosyncratic reaction to 5-ASA therapy. The precise
pathogenic mechanisms are unknown. This study aims to a) describe the clinical features of …

[CITATION][C] 5‐aminosalicylates in inflammatory bowel disease and chronic renal failure

F Tekin, O Ozutemiz, T Ilter - Alimentary pharmacology & …, 2005 - Wiley Online Library
AP&T correspondence columns are restricted to letters discussing papers that have been
published in the journal. A letter must have a maximum of 300 words, may contain one table …

Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease

GA Heap, K So, M Weedon, N Edney… - Journal of Crohn's …, 2016 - academic.oup.com
Abstract Background and Aims Nephrotoxicity is a rare idiosyncratic reaction to 5-
aminosalicylate (5-ASA) therapies. The aims of this study were to describe the clinical …

Chronic tubulointerstitial nephritis induced by 5-aminosalicylate in an ulcerative colitis patient: a rare but serious adverse event

P Magalhães-Costa, L Matos, C Chagas - Case Reports, 2015 - casereports.bmj.com
The 5-aminosalicylate is widely prescribed in inflammatory bowel disease patients. Its
potential for renal damage has been seldom described. We report a case of a 23-year-old …